Accenture Forges AI Alliances with Amadeus and AlphaSense as Broker Skepticism and Share Price Slide Persist

Accenture announces AI partnerships with Amadeus and AlphaSense, but shares fall 30% YTD as analysts cut targets on competition and geopolitical risks.

Accenture is doubling down on artificial intelligence partnerships even as its stock languishes well off its highs and analysts grow increasingly wary of the headwinds facing the consulting giant. Two new deals — one with travel technology firm Amadeus and another with market intelligence platform AlphaSense — aim to deepen the company’s AI footprint across industries, but the market has yet to reward the strategy.

The collaboration with Amadeus will launch a new AI-powered advertising platform for the travel sector. Designed to replace Amadeus’s existing ad business, the platform merges Amadeus’s demand data with Accenture’s campaign management technology. The goal is to help travel brands spot trends earlier and fine?tune digital campaigns. The platform was unveiled at Amadeus’s first Advertising Summit in Antibes, France, marking a significant push into travel?sector AI.

Separately, Accenture Ventures is investing in AlphaSense, a platform that scours a library of over 500 million business documents to deliver real?time analysis and market intelligence. By combining AlphaSense’s data with Accenture’s industry expertise, the pair plan to build what they call “agentic workflows” — processes where AI systems autonomously prepare decisions and trigger actions. The investment signals Accenture’s ambition to embed its services deeper into corporate decision?making.

These strategic moves, however, have done little to lift the share price. On Friday, Accenture’s stock rose 1.08% to close at €154.85, according to one source, while another report put the closing price at €154.70. Either way, the gain is a drop in the ocean. Year?to?date, the shares have tumbled 30.2%, and compared to a year ago they are 43.83% lower. The 52?week high of €280.90 remains nearly 45% out of reach.

Analyst sentiment reflects the disconnect between Accenture’s AI push and the market’s doubts. Wells Fargo reaffirmed its “Overweight” rating but slashed its price target from $275 to $248. Goldman Sachs stuck with “Buy” but cut its target from $300 to $270, citing geopolitical disruptions that are weighing on client spending. Truist Securities took a more aggressive step, downgrading the stock from “Buy” to “Hold” and reducing its target from $260 to $210. Truist’s rationale: pure?play AI firms are intensifying competition, and AI itself risks cannibalizing traditional billable consulting hours.

The company’s financials so far paint a picture of solid but uninspiring growth. In its fiscal second quarter, Accenture reported revenue of $18.0 billion, an 8% increase, and earnings per share of $2.93, up 4%. For the third quarter, which ended in May, management guided revenue between $18.35 billion and $19.0 billion. The full?year forecast calls for local?currency revenue growth of 3% to 5%, with adjusted EPS in a range of $13.65 to $13.90 — representing a 6% to 8% advance.

The next big test comes on June 18, when Accenture releases its fiscal third?quarter results. Investors will be watching closely to see whether the AI partnerships are translating into measurable revenue — and whether the analyst downgrades were justified or overly pessimistic. For now, the gap between Accenture’s strategic ambitions and its stock price remains wide.